[The effect of topiramate or carbamazepine treatment on the quality of life in patients with vestibular paroxysmia].
Objective:To study the effect of topiramate or carbamazepine treatment on the quality of life (QOL) in patients with vestibular paroxysmia(VP).Method:Thirty-five cases diagnosed as VP from September 2012 to September 2015 were retrospectively studied. Medical outcomes study short form(SF-36)and the dizziness handicap inventory(DHI) were used to analyze the QOL.Result:After topiramate or carbamazepine treatment for one month, the scores of physical function, role physical, general health, vitality, social functioning, role emotional in SF-36 were significantly increased than pre-treatment(P< 0.01); and the scores of emotion, function and physiology in DHI were significantly decreased than pre-treatment(P< 0.01).Conclusion:Topiramate and carbamazepine may obviously improve the QOL of VP patients.The SF-36 and DHI scales could reflect the change of QOL in VP patients.